Showing results (791-800 of 824) with videos related to
Sort By:
Pageof 83
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2022
Famitinib with Camrelizumab and Nab-Paclitaxel for Advanced Immunomodulatory Triple-Negative Breast Cancer (FUTURE-C-Plus): An Open-Label, Single-Arm, Phase II TrialLi Chen, Yi-Zhou Jiang, Song-Yang Wu, et al.Endocrine-Related Cancer|September 1, 2025
Neoadjuvant palbociclib in women with operable, hormone receptor-positive breast cancerTakayuki Ueno, Louis W C Chow, Wonshik Han, et al.Nature Communications|May 14, 2021
Human ribonuclease 1 serves as a secretory ligand of ephrin A4 receptor and induces breast tumor initiationHeng-Huan Lee, Ying-Nai Wang, Wen-Hao Yang, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 18, 2020
Neratinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in HER2-Positive Metastatic Breast Cancer Previously Treated With ≥ 2 HER2-Directed Regimens: Phase III NALA TrialCristina Saura, Mafalda Oliveira, Yin-Hsun Feng, et al.Medical Image Analysis|October 13, 2020
The state of the art in kidney and kidney tumor segmentation in contrast-enhanced CT imaging: Results of the KiTS19 challengeNicholas Heller, Fabian Isensee, Klaus H Maier-Hein, et al.Lancet (London, England)|December 11, 2012
Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trialChristina Davies, Hongchao Pan, Jon Godwin, et al.American Heart Journal|February 22, 2023
Prospective randomized comparison between upgraded '2C3L' vs. PVI approach for catheter ablation of persistent atrial fibrillation: PROMPT-AF trial designXiao-Xia Liu, Qiang Liu, Yi-Wei Lai, et al.Plos Genetics|June 30, 2010
Identification of a functional genetic variant at 16q12.1 for breast cancer risk: results from the Asia Breast Cancer ConsortiumJirong Long, Qiuyin Cai, Xiao-Ou Shu, et al.Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|April 11, 2022
Potent Anti-SARS-CoV-2 Efficacy of COVID-19 Hyperimmune Globulin from Vaccine-Immunized PlasmaDing Yu, Yu-Feng Li, Hong Liang, et al.Breast Cancer (Tokyo, Japan)|May 11, 2022
Relevance of the MHC region for breast cancer susceptibility in AsiansPeh Joo Ho, Alexis Jiaying Khng, Benita Kiat-Tee Tan, et al.Pageof 83